Guangyuyuan released its 2026 interim report. Total operating revenue was 824 million yuan, up 5.78% year on year. Net profit attributable to the parent company was 84.6573 million yuan, up 10.15% year on year, marking a fifth consecutive year of growth. Net cash inflow from operating activities was 282 million yuan, up 14.55% year on year. The company's asset-liability ratio was 33.39%, gross margin was 66.80%, return on equity was 5.08%, and earnings per share were 0.17 yuan. The number of shareholders was 61,600, and the top ten shareholders held 22.35% of total share capital.
GuangYuYuan Chinese Herbal Medicine Co LtdNet profit up 10.15% year on year, fifth consecutive year of growth.
